A L Verbeek
Overview
Explore the profile of A L Verbeek including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
180
Citations
2010
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
van Dijck J, Hendriks J, Verbeek A, Kiemeney L
Ned Tijdschr Geneeskd
. 2004 May;
148(17):828-35.
PMID: 15141650
Objective: To analyze the risk of cancer in the population of Weurt, a village near Nijmegen, the Netherlands, using long-term data (13 years). Design: Cluster analysis. Method: Anonymous data on...
2.
Fracheboud J, de Koning H, Boer R, Groenewoud J, Verbeek A, Broeders M, et al.
Breast
. 2004 Feb;
10(1):6-11.
PMID: 14965550
The period 1990-1997 saw the implementation of a nationwide breast cancer screening programme in the Netherlands, which provided biennial mammography for all women aged 50-69 years (50-75 years at present)....
3.
JACOBS E, Verbeek A, Swinkels D
Ned Tijdschr Geneeskd
. 2003 Dec;
147(46):2304-5.
PMID: 14655303
No abstract available.
4.
Beckerman H, Roebroeck M, Lankhorst G, Becher J, Bezemer P, Verbeek A
Qual Life Res
. 2002 Feb;
10(7):571-8.
PMID: 11822790
The aim of this study is to show the relationship between test-retest reproducibility and responsiveness and to introduce the smallest real difference (SRD) approach, using the sickness impact profile (SIP)...
5.
Severens J, Sonke G, Laheij R, Verbeek A, de Vries Robbe P
J Clin Epidemiol
. 2001 Dec;
54(12):1228-37.
PMID: 11750191
Excessive diagnostic testing rarely leads to complete certainty of the disease status of a patient. Because of constraints of health care budgets, physicians should be aware of the diminishing marginal...
6.
Van Loenhout-Rooyackers J, Keyser A, Laheij R, Verbeek A, van der Meer J
Int J Tuberc Lung Dis
. 2001 Nov;
5(11):1028-35.
PMID: 11716339
Setting: The British Thoracic Society and the American Thoracic Society advise 12 months treatment for tuberculous meningitis, with at least isoniazid (H), rifampicin (R) and pyrazinamide (Z). Objective: To establish...
7.
JACOBS H, van Dijck J, de Kleijn E, Kiemeney L, Verbeek A
Ann Oncol
. 2001 Oct;
12(8):1107-13.
PMID: 11583192
Background: Little is known about the effects of routine follow-up examinations on life expectancy in cancer patients. Lately, the benefits of follow-up examinations have been debated, which has given rise...
8.
van Dijck J, Festen J, de Kleijn E, Kramer G, Tjan-Heijnen V, Verbeek A
Lung Cancer
. 2001 Sep;
34(1):19-27.
PMID: 11557109
The purpose of this study was to gain insight into the treatment policy and survival of patients with non-small cell lung cancer (NSCLC) clinical stage IIIA in daily practice. We...
9.
Laheij R, Jansen J, Verbeek A, Verheugt F
Aliment Pharmacol Ther
. 2001 Jun;
15(7):1055-9.
PMID: 11421882
Background: Aspirin use in the secondary prevention of ischaemic heart disease may provoke gastrointestinal discomfort. Objective: To register gastrointestinal symptoms and complications in patients with cardiovascular disease using aspirin and...
10.
Janssen M, van Oijen A, Verbeek A, Jansen J, de Boer W
Aliment Pharmacol Ther
. 2001 May;
15(5):613-24.
PMID: 11328254
Background: Triple therapies with proton pump inhibitor/ranitidine bismuth citrate (RBC), clarithromycin (C) and either amoxicillin (A) or a nitroimidazole (I) are widely accepted as treatment for Helicobacter pylori infection. However,...